SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO (Q106460748)

1

0 references

Yuheng Shi

2

0 references

Xiaoyan Pan

3

0 references

Shuang Wu

4

0 references

Ruixia Hou

5

0 references

Yong Zhang

6

0 references

Tiansheng Zhong

7

0 references

Hao Tang

8

0 references

Wei Du

9

0 references

Luying Wang

10

0 references

Jing Wo

11

0 references

Jingfang Mu

12

0 references

Yang Qiu

13

0 references

Ke Yang

14

0 references

Lei-Ke Zhang

15

0 references

Bang-Ce Ye

16

0 references

Nan Qi

Evidence of SARS-CoV-2 RNA in an Oropharyngeal Swab Specimen, Milan, Italy, Early December 2019

17

0 references

publication date

February 2021

0 references

published in

Cell Reports

0 references

volume

34

0 references

issue

7

0 references

page(s)

108761

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016/J.CELREP.2021.108761

Polyubiquitin conjugation to NEMO by triparite motif protein 23 (TRIM23) is critical in antiviral defense

11 April 2021

1 reference

https://api.crossref.org/works/10.1016/J.CELREP.2021.108761

Ubiquitylation in innate and adaptive immunity.

11 April 2021

1 reference

https://api.crossref.org/works/10.1016/J.CELREP.2021.108761

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19

11 April 2021

1 reference

https://api.crossref.org/works/10.1016/J.CELREP.2021.108761

Proteomics of SARS-CoV-2-infected host cells reveals therapy targets

11 April 2021

1 reference

https://api.crossref.org/works/10.1016/J.CELREP.2021.108761

In vitro reconstitution of SARS-coronavirus mRNA cap methylation

11 April 2021

1 reference

https://api.crossref.org/works/10.1016/J.CELREP.2021.108761

Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon

11 April 2021

1 reference

https://api.crossref.org/works/10.1016/J.CELREP.2021.108761

IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes

11 April 2021

1 reference

https://api.crossref.org/works/10.1016/J.CELREP.2021.108761

Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus

11 April 2021

1 reference

https://api.crossref.org/works/10.1016/J.CELREP.2021.108761

IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway

11 April 2021

1 reference

https://api.crossref.org/works/10.1016/J.CELREP.2021.108761

Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane

11 April 2021

1 reference

https://api.crossref.org/works/10.1016/J.CELREP.2021.108761

Transmission of innate immune signaling by packaging of cGAMP in viral particles

11 April 2021

1 reference

https://api.crossref.org/works/10.1016/J.CELREP.2021.108761

Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms

11 April 2021

1 reference

https://api.crossref.org/works/10.1016/J.CELREP.2021.108761

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

11 April 2021

1 reference

https://api.crossref.org/works/10.1016/J.CELREP.2021.108761

Bile Acids Control Inflammation and Metabolic Disorder through Inhibition of NLRP3 Inflammasome.

11 April 2021

1 reference

https://api.crossref.org/works/10.1016/J.CELREP.2021.108761

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

11 April 2021

1 reference

https://api.crossref.org/works/10.1016/J.CELREP.2021.108761

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

11 April 2021

1 reference

https://api.crossref.org/works/10.1016/J.CELREP.2021.108761

Mechanisms of MAVS regulation at the mitochondrial membrane

11 April 2021

1 reference

https://api.crossref.org/works/10.1016/J.CELREP.2021.108761

SARS-CoV-2 proteome microarray for global profiling of COVID-19 specific IgG and IgM responses

11 April 2021

1 reference

https://api.crossref.org/works/10.1016/J.CELREP.2021.108761

SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70

11 April 2021

1 reference

https://api.crossref.org/works/10.1016/J.CELREP.2021.108761

Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses

11 April 2021

1 reference

https://api.crossref.org/works/10.1016/J.CELREP.2021.108761

Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists

11 April 2021

1 reference

https://api.crossref.org/works/10.1016/J.CELREP.2021.108761

Activation and evasion of type I interferon responses by SARS-CoV-2

11 April 2021

1 reference

https://api.crossref.org/works/10.1016/J.CELREP.2021.108761

Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation

11 April 2021

1 reference

https://api.crossref.org/works/10.1016/J.CELREP.2021.108761

MAVS recruits multiple ubiquitin E3 ligases to activate antiviral signaling cascades

11 April 2021

1 reference

https://api.crossref.org/works/10.1016/J.CELREP.2021.108761

Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2'-o-methyltransferase activity

11 April 2021

1 reference

https://api.crossref.org/works/10.1016/J.CELREP.2021.108761

Type I and Type III Interferons - Induction, Signaling, Evasion, and Application to Combat COVID-19

11 April 2021

1 reference

https://api.crossref.org/works/10.1016/J.CELREP.2021.108761

Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study

11 April 2021

1 reference

https://api.crossref.org/works/10.1016/J.CELREP.2021.108761

Dysregulation of immune response in patients with COVID-19 in Wuhan, China

11 April 2021

1 reference

https://api.crossref.org/works/10.1016/J.CELREP.2021.108761

Deciphering key features in protein structures with the new ENDscript server

11 April 2021

1 reference

https://api.crossref.org/works/10.1016/J.CELREP.2021.108761

IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex

11 April 2021

1 reference

https://api.crossref.org/works/10.1016/J.CELREP.2021.108761

MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV.

11 April 2021

1 reference

https://api.crossref.org/works/10.1016/J.CELREP.2021.108761

SARS-coronavirus open reading frame-9b suppresses innate immunity by targeting mitochondria and the MAVS/TRAF3/TRAF6 signalosome

11 April 2021

1 reference

https://api.crossref.org/works/10.1016/J.CELREP.2021.108761

Upstream ORFs Prevent MAVS Spontaneous Aggregation and Regulate Innate Immune Homeostasis

11 April 2021

1 reference

https://api.crossref.org/works/10.1016/J.CELREP.2021.108761

Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China

11 April 2021

1 reference

https://api.crossref.org/works/10.1016/J.CELREP.2021.108761

Immune suppression in the early stage of COVID-19 disease

11 April 2021

1 reference

https://api.crossref.org/works/10.1016/J.CELREP.2021.108761

Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection

11 April 2021

1 reference

https://api.crossref.org/works/10.1016/J.CELREP.2021.108761

Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus

11 April 2021

1 reference

https://api.crossref.org/works/10.1016/J.CELREP.2021.108761

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

11 April 2021

1 reference

https://api.crossref.org/works/10.1016/J.CELREP.2021.108761

Virological assessment of hospitalized patients with COVID-2019

11 April 2021

1 reference

https://api.crossref.org/works/10.1016/J.CELREP.2021.108761

Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected]

11 April 2021

1 reference

https://api.crossref.org/works/10.1016/J.CELREP.2021.108761

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

11 April 2021

1 reference

https://api.crossref.org/works/10.1016/J.CELREP.2021.108761

Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2

11 April 2021

1 reference

https://api.crossref.org/works/10.1016/J.CELREP.2021.108761

The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists

11 April 2021

1 reference

https://api.crossref.org/works/10.1016/J.CELREP.2021.108761

SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists

11 April 2021

1 reference

https://api.crossref.org/works/10.1016/J.CELREP.2021.108761

A pneumonia outbreak associated with a new coronavirus of probable bat origin

11 April 2021

1 reference

https://api.crossref.org/works/10.1016/J.CELREP.2021.108761

A Novel Coronavirus from Patients with Pneumonia in China, 2019

11 April 2021

1 reference

https://api.crossref.org/works/10.1016/J.CELREP.2021.108761

SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients

11 April 2021

1 reference

https://api.crossref.org/works/10.1016/J.CELREP.2021.108761